CAMPHOR AND MENTHOL

N/A

Manufactured by Bayer HealthCare LLC

75 FDA adverse event reports analyzed

Last updated: 2026-04-15

About CAMPHOR AND MENTHOL

CAMPHOR AND MENTHOL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Bayer HealthCare LLC. The most commonly reported adverse reactions for CAMPHOR AND MENTHOL include DRUG INEFFECTIVE, CHOKING, DYSPNOEA, ABDOMINAL DISCOMFORT, APPLICATION SITE PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CAMPHOR AND MENTHOL.

Top Adverse Reactions

DRUG INEFFECTIVE8 reports
CHOKING4 reports
DYSPNOEA4 reports
ABDOMINAL DISCOMFORT3 reports
APPLICATION SITE PAIN3 reports
NAUSEA3 reports
APPLICATION SITE PRURITUS2 reports
DYSPEPSIA2 reports
HAEMORRHAGE2 reports
HYPOAESTHESIA2 reports
PRODUCT ODOUR ABNORMAL2 reports
PRODUCT USE ISSUE2 reports
ABDOMINAL DISTENSION1 reports
ACCIDENTAL EXPOSURE TO PRODUCT1 reports
APPLICATION SITE EXFOLIATION1 reports
BELL^S PALSY1 reports
BLISTER1 reports
DIARRHOEA1 reports
DRUG EFFECTIVE FOR UNAPPROVED INDICATION1 reports
DRUG HYPERSENSITIVITY1 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION1 reports
DRY SKIN1 reports
ERYTHEMA1 reports
EXPIRED PRODUCT ADMINISTERED1 reports
EXPOSURE VIA INHALATION1 reports
GAIT DISTURBANCE1 reports
GASTROINTESTINAL DISORDER1 reports
HEADACHE1 reports
HYPERSENSITIVITY1 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION1 reports
INCORRECT DOSE ADMINISTERED1 reports
IRON DEFICIENCY ANAEMIA1 reports
MALAISE1 reports
OFF LABEL USE1 reports
PARAESTHESIA1 reports
PARALYSIS1 reports
PNEUMOTHORAX1 reports
PRODUCT CLOSURE ISSUE1 reports
PRODUCT COMPLAINT1 reports
PRODUCT FORMULATION ISSUE1 reports
PRODUCT LOT NUMBER ISSUE1 reports
PRODUCT PACKAGING CONFUSION1 reports
PRODUCT USE COMPLAINT1 reports
SKIN DISCOLOURATION1 reports
SKIN FISSURES1 reports
SKIN INJURY1 reports
SKIN REACTION1 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE1 reports
THERAPEUTIC PRODUCT EFFECT VARIABLE1 reports
THERAPEUTIC PRODUCT INEFFECTIVE1 reports

Report Outcomes

Out of 30 classified reports for CAMPHOR AND MENTHOL:

Serious 43.3%Non-Serious 56.7%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female17 (77.3%)
Male5 (22.7%)

Reports by Age

Age 612 reports
Age 722 reports
Age 351 reports
Age 501 reports
Age 561 reports
Age 601 reports
Age 621 reports
Age 631 reports
Age 701 reports
Age 731 reports
Age 741 reports
Age 911 reports
Age 931 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CAMPHOR AND MENTHOL?

This profile reflects 75 FDA FAERS reports that mention CAMPHOR AND MENTHOL. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CAMPHOR AND MENTHOL?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, CHOKING, DYSPNOEA, ABDOMINAL DISCOMFORT, APPLICATION SITE PAIN, NAUSEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CAMPHOR AND MENTHOL?

Labeling and FAERS entries often list Bayer HealthCare LLC in connection with CAMPHOR AND MENTHOL. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.